Legacy Drugs Collected Jan1.12toSept.12: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ttenbergen (talk | contribs) mNo edit summary |
||
(33 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{LegacyContent | |||
|explanation=Various changes happened after that see [[Pharmacy collection#Legacy Info]] for summary of changes over time | |||
|successor= [[Pharmacy collection]] | |||
|content= | |||
*Start date of this list Jan 1.12 | |||
*End date of this list Sept ??.12 | |||
**Since folks were told to start using new list sometime in the beginning of sept with YES and NO ,when is actually the end date for this list? Good for Julie to know.[[User:TOstryzniuk|Trish Ostryzniuk]] ([[User talk:TOstryzniuk|talk]]) 19:36, 2012 September 20 (CDT) | |||
== List Outdated == | |||
*The new drug list (sept 25.12) reduces the workload of pharmacy collection. Final approval from steering committee for new list will be obtained Sept 10.12. There are number of drug groups that will be Yes and No only, and other eliminated. I have send everyone a copy of the list today so you can look at what is coming.[[User:TOstryzniuk|Trish Ostryzniuk]] 10:56, 2012 September 7 (CDT) | |||
{| class="wikitable sortable" | |||
{| class="wikitable sortable" | |||
|- | |- | ||
! sort order | |||
! count | |||
! identifier | |||
! drugs in group | |||
! drugs eliminated Sept ?.12 | |||
|- | |- | ||
|| 1 | || 1 | ||
|| yes | || yes | ||
|| PPI | || PPI (Proton Pump Inhibitor) | ||
|| esomeprazole (nexium), pantoprazole (pantaloc) , omeprazole (pilosec), rabeprazole (aciphex), lansoprazole (prevacid), dexlansoprazole (kapidex or dexilant) | || esomeprazole (nexium), pantoprazole (pantaloc) , omeprazole (pilosec), rabeprazole (aciphex), lansoprazole (prevacid), dexlansoprazole (kapidex or dexilant) | ||
|| | |||
|- | |- | ||
Line 29: | Line 29: | ||
|| H2-Blockers | || H2-Blockers | ||
|| ranitidine (zantac), famotidine (pepcid), cimetidine (tagamet), nizatidine (tazac) | || ranitidine (zantac), famotidine (pepcid), cimetidine (tagamet), nizatidine (tazac) | ||
|| | |||
|- | |- | ||
Line 35: | Line 36: | ||
|| Vitamin K antagonists | || Vitamin K antagonists | ||
|| warfarin (coumadin), acenocoumarol (sintrom or sinthrome) | || warfarin (coumadin), acenocoumarol (sintrom or sinthrome) | ||
|| | |||
|- | |- | ||
Line 41: | Line 43: | ||
|| Heparin SQ | || Heparin SQ | ||
|| | || | ||
|| | |||
|- | |- | ||
Line 47: | Line 50: | ||
|| Heparin continous IV inf | || Heparin continous IV inf | ||
|| by IV continuous infusion only | || by IV continuous infusion only | ||
|| | |||
|- | |- | ||
|| 6 | || 6 | ||
|| yes | || yes | ||
|| LMWH | || LMWH (Low Molecular Weight Heparin) | ||
|| dalteparin (fragmin), enoxaparin (Lovenox), tinzaparin (innohep), nadroparin (fraxiparin) | || dalteparin (fragmin), enoxaparin (Lovenox), tinzaparin (innohep), nadroparin (fraxiparin) | ||
|| | |||
|- | |- | ||
Line 60: | Line 64: | ||
|| Direct thrombin inhibitors | || Direct thrombin inhibitors | ||
|| argatroban, bivalirudin (angiomax), lepirudin (refludan), dabigatran (Pradax) | || argatroban, bivalirudin (angiomax), lepirudin (refludan), dabigatran (Pradax) | ||
|| | |||
|- | |- | ||
Line 66: | Line 71: | ||
|| Heparinoids | || Heparinoids | ||
|| danaparoid (Orgaran-DVT, Orgaran (HIT)) | || danaparoid (Orgaran-DVT, Orgaran (HIT)) | ||
|| | |||
|- | |- | ||
Line 72: | Line 78: | ||
|| Factor Xa inhibitors | || Factor Xa inhibitors | ||
|| Fondaparinux (arixtra), Rivaroxaban (xarelto) | || Fondaparinux (arixtra), Rivaroxaban (xarelto) | ||
|| | |||
|- | |- | ||
Line 78: | Line 85: | ||
|| benzodiazepines continuous IV inf | || benzodiazepines continuous IV inf | ||
|| lorazepam (ativan), diazepam (valium), midazolam (versed) | || lorazepam (ativan), diazepam (valium), midazolam (versed) | ||
|| | |||
|- | |- | ||
Line 84: | Line 92: | ||
|| opioids '''continuous'''''' IV inf''' | || opioids '''continuous'''''' IV inf''' | ||
|| alfentanil (alfenta), fentanyl (sublimaze), hydromorphone (dilaudid), morphine, meperidine (demerol), sufentanil(sufenta) NOTE: does not include PCA which is intermittent. As discussed and agreed by ICU task team - Dr. Allan Garland. | || alfentanil (alfenta), fentanyl (sublimaze), hydromorphone (dilaudid), morphine, meperidine (demerol), sufentanil(sufenta) NOTE: does not include PCA which is intermittent. As discussed and agreed by ICU task team - Dr. Allan Garland. | ||
|| | |||
|- | |- | ||
Line 90: | Line 99: | ||
|| propofol continuous IV inf | || propofol continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
Line 96: | Line 106: | ||
|| Dopamine continuous IV inf | || Dopamine continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
Line 102: | Line 113: | ||
|| Dobutamine continuous IV inf | || Dobutamine continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
|| 15 | || 15 | ||
|| yes | || yes | ||
|| Norepinephrine | || Norepinephrine continuous IV inf | ||
|| | || Levophed | ||
|| | |||
|- | |- | ||
Line 114: | Line 127: | ||
|| Epinephrine continuous IV inf | || Epinephrine continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
|| 17 | || 17 | ||
|| yes | || yes | ||
|| Phenylephrine | || Phenylephrine continuous IV inf | ||
|| | || Neo-Synephrine | ||
|| | |||
|- | |- | ||
Line 126: | Line 141: | ||
|| Vasopressin continuous IV inf | || Vasopressin continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
Line 132: | Line 148: | ||
|| Milrinone continuous IV inf | || Milrinone continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
|| 20 | || 20 | ||
|| yes | || yes | ||
|| Nitroprusside | || Nitroprusside continuous IV inf | ||
|| | || Nipride | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 144: | Line 162: | ||
|| Nitroglycerine continuous IV inf | || Nitroglycerine continuous IV inf | ||
|| | || | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 150: | Line 169: | ||
|| Insulin continuous IV inf | || Insulin continuous IV inf | ||
|| | || | ||
|| | |||
|- | |- | ||
|| 23 | || 23 | ||
|| yes | || yes | ||
|| Furosemide | || Furosemide continuous IV inf | ||
|| | || Lasix | ||
|| | |||
|- | |- | ||
Line 162: | Line 183: | ||
|| Paralytics '''continuous IV inf''' | || Paralytics '''continuous IV inf''' | ||
|| rocuronium (esmeron), atracurium, pancuronium (pavulon), cisatracurium We do not collect epidural or intravertebral only IV. | || rocuronium (esmeron), atracurium, pancuronium (pavulon), cisatracurium We do not collect epidural or intravertebral only IV. | ||
|| | |||
|- | |- | ||
Line 168: | Line 190: | ||
|| corticosteroids IV or Oral | || corticosteroids IV or Oral | ||
|| (NOT fludrocortisone);(betamethasone, cortisone, hydrocortisone (Solu-Cortef), methylprednisolone (Solu-Medrol), prednisone, dexamethasone (decadron), budesonide (Entocort), prednisolone, triamcinolone (tricortone) | || (NOT fludrocortisone);(betamethasone, cortisone, hydrocortisone (Solu-Cortef), methylprednisolone (Solu-Medrol), prednisone, dexamethasone (decadron), budesonide (Entocort), prednisolone, triamcinolone (tricortone) | ||
|| | |||
|- | |- | ||
|| 26 | || 26 | ||
|| yes | || yes | ||
|| fludrocortisone | || fludrocortisone | ||
|| | || Florinef emailed Allan Garland whether this should now be included under corticosteroids | ||
|| | |||
|- | |- | ||
Line 180: | Line 204: | ||
|| azoles '''(anti-fungal)''' | || azoles '''(anti-fungal)''' | ||
|| fluconazole (diflucan), itraconazole (sporanox), ketoconazole (ziroral), posaconazole (posanol), voriconazole (Vfend). | || fluconazole (diflucan), itraconazole (sporanox), ketoconazole (ziroral), posaconazole (posanol), voriconazole (Vfend). | ||
|| | |||
|- | |- | ||
Line 186: | Line 211: | ||
|| amphotericin B | || amphotericin B | ||
|| amphotericin B (Fungizone), amphotericin B lipid complex, amphotericin B liposomal | || amphotericin B (Fungizone), amphotericin B lipid complex, amphotericin B liposomal | ||
|| | |||
|- | |- | ||
|| 29 | || 29 | ||
|| yes | || yes | ||
|| fungins IV | || fungins IV (Anti-fungal) | ||
|| caspofungin (Cancidas), micafungin (Mycamine) , anidulafungin (Eraxis) | || caspofungin (Cancidas), micafungin (Mycamine) , anidulafungin (Eraxis) | ||
|| | |||
|- | |- | ||
Line 199: | Line 225: | ||
|| antipseudomonal PCNs | || antipseudomonal PCNs | ||
|| piperacillin, piperacillin/tazobactam (Tazocin), ticarcillin, ticarcillin/clavulanate (Timentin) | || piperacillin, piperacillin/tazobactam (Tazocin), ticarcillin, ticarcillin/clavulanate (Timentin) | ||
|| | |||
|- | |- | ||
|| 31 | || 31 | ||
|| yes | || yes | ||
|| vancomycin | || vancomycin | ||
|| | || Vancocin | ||
|| | |||
|- | |- | ||
Line 211: | Line 239: | ||
|| macrolides | || macrolides | ||
|| erythromycin (oral: Eryc), azithromycin (Zithromax), clarithromycin (Biaxin), telithromycin (Ketek) | || erythromycin (oral: Eryc), azithromycin (Zithromax), clarithromycin (Biaxin), telithromycin (Ketek) | ||
|| | |||
|- | |- | ||
Line 217: | Line 246: | ||
|| fluoroquinolones | || fluoroquinolones | ||
|| ciprofloxacin (Cipro), moxifloxacin (Avelox), levofloxacin (Levaquin), norfloxacin (Noroxin), ofloxacin (Floxin) | || ciprofloxacin (Cipro), moxifloxacin (Avelox), levofloxacin (Levaquin), norfloxacin (Noroxin), ofloxacin (Floxin) | ||
|| | |||
|- | |- | ||
Line 223: | Line 253: | ||
|| carbapenems | || carbapenems | ||
|| (NOT ertapenem); meropenem (Merrem), imipenem (Primaxin), doripenem (Doribax) | || (NOT ertapenem); meropenem (Merrem), imipenem (Primaxin), doripenem (Doribax) | ||
|| | |||
|- | |- | ||
|| 35 | || 35 | ||
|| yes | || yes | ||
|| ertapenem | || ertapenem | ||
|| | || Invanz | ||
|| | |||
|- | |- | ||
Line 235: | Line 267: | ||
|| vanco alternatives | || vanco alternatives | ||
|| linezolid (Zyvoxam), daptomycin (Cubicin), quinipristin/dalfopristin | || linezolid (Zyvoxam), daptomycin (Cubicin), quinipristin/dalfopristin | ||
|| | |||
|- | |- | ||
Line 241: | Line 274: | ||
|| 1st or 2nd generation cephalosporins | || 1st or 2nd generation cephalosporins | ||
|| cefazolin, cephalexin (oral: Novo-Lexin, Nu-Cephalex, Keflex), cefadroxil, cefuroxime (Ceftin), cefoxitin, cefprozil (Cefzil), cefaclor | || cefazolin, cephalexin (oral: Novo-Lexin, Nu-Cephalex, Keflex), cefadroxil, cefuroxime (Ceftin), cefoxitin, cefprozil (Cefzil), cefaclor | ||
|| | |||
|- | |- | ||
Line 247: | Line 281: | ||
|| 3rd generation cephalosporins | || 3rd generation cephalosporins | ||
|| (NOT ceftazidime); ceftriaxone (Rocephin), cefotaxime (Claforan), cefixime (Suprax) | || (NOT ceftazidime); ceftriaxone (Rocephin), cefotaxime (Claforan), cefixime (Suprax) | ||
|| | |||
|- | |- | ||
|| 39 | || 39 | ||
|| yes | || yes | ||
|| ceftazidime | || ceftazidime | ||
|| | || Fortaz | ||
|| | |||
|- | |- | ||
Line 259: | Line 295: | ||
|| 4th generation cephalosporins | || 4th generation cephalosporins | ||
|| cefepime (Maxipime) | || cefepime (Maxipime) | ||
|| | |||
|- | |- | ||
Line 265: | Line 302: | ||
|| antistaph penicillins | || antistaph penicillins | ||
|| cloxacillin, oxacillin | || cloxacillin, oxacillin | ||
|| | |||
|- | |- | ||
Line 271: | Line 309: | ||
|| aminoglycosides | || aminoglycosides | ||
|| gentamicin, tobramicin (Tobrex), amikacin, neomycin, streptomycin, netilmycin | || gentamicin, tobramicin (Tobrex), amikacin, neomycin, streptomycin, netilmycin | ||
|| | |||
|- | |- | ||
|| 43 | || 43 | ||
|| yes | || yes | ||
|| tigecycline | || tigecycline | ||
|| | || Tygacil | ||
|| | |||
|- | |- | ||
Line 283: | Line 323: | ||
|| clositin | || clositin | ||
|| | || | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 289: | Line 330: | ||
|| anti-CMV drugs | || anti-CMV drugs | ||
|| ganciclovir (Cytovene), valganciclovir (Valcyte)We do not collect valacyclovir(Valtrex) | || ganciclovir (Cytovene), valganciclovir (Valcyte)We do not collect valacyclovir(Valtrex) | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 294: | Line 336: | ||
|| yes | || yes | ||
|| foscarnet IV | || foscarnet IV | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 300: | Line 343: | ||
|| acyclovir IV or Oral | || acyclovir IV or Oral | ||
|| Acyclovir Sodium IV, Zovirax Oral | || Acyclovir Sodium IV, Zovirax Oral | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 306: | Line 350: | ||
|| influenza drugs | || influenza drugs | ||
|| tamiflu, oseltamivir (Tamiflu), zanamivir (Relenza) | || tamiflu, oseltamivir (Tamiflu), zanamivir (Relenza) | ||
|| | |||
|- | |- | ||
|| 50 | || 50 | ||
|| no | || no | ||
|| epoprostinol IV | || epoprostinol IV | ||
|| | || Epoprostenal: Flolan for Injection | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
|| 51 | || 51 | ||
|| no | || no | ||
|| bosentan | || bosentan | ||
|| | || Tracleer Oral | ||
|| | |||
|- | |- | ||
Line 324: | Line 371: | ||
|| viagra-type vasodilators | || viagra-type vasodilators | ||
|| Sildenafil (Revatio or Viagra),Tadalafil (Cialis) | || Sildenafil (Revatio or Viagra),Tadalafil (Cialis) | ||
|| | |||
|- | |- | ||
Line 330: | Line 378: | ||
|| EPO-type drugs | || EPO-type drugs | ||
|| darbepoetin (aranesp), epoetin alpha (Eprex), eltrombopag, filgrastim (neupogen), pegfilgrastim (neulasta), romiplostim (Nplate), erthyropoietin | || darbepoetin (aranesp), epoetin alpha (Eprex), eltrombopag, filgrastim (neupogen), pegfilgrastim (neulasta), romiplostim (Nplate), erthyropoietin | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 336: | Line 385: | ||
|| immunosuppressives | || immunosuppressives | ||
|| cyclophosphamide (Procytox), azathioprine (Imuran), mycophenylate ( CellCept (oral/IV) Myfortic(oral)); cyclosporin (Neoral (oral)) (Sandimmune IV), tacrolimus (Advagraf (oral); Prograf-(oral/IV)) | || cyclophosphamide (Procytox), azathioprine (Imuran), mycophenylate ( CellCept (oral/IV) Myfortic(oral)); cyclosporin (Neoral (oral)) (Sandimmune IV), tacrolimus (Advagraf (oral); Prograf-(oral/IV)) | ||
|| eliminated | |||
|- | |- | ||
Line 342: | Line 392: | ||
|| biologics | || biologics | ||
|| infliximab (remicade), adilumumab, etanercept (enbrel), abciximab (ReoPro), trastuzumab (herceptin), rituximab (rituxan), eptifibatide (integrilin), tirofiban (Aggrastat) | || infliximab (remicade), adilumumab, etanercept (enbrel), abciximab (ReoPro), trastuzumab (herceptin), rituximab (rituxan), eptifibatide (integrilin), tirofiban (Aggrastat) | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 349: | Line 399: | ||
|| special upper GI bleeding agents | || special upper GI bleeding agents | ||
|| octreotide (sandostatin) or somatostatin (Stilamin) | || octreotide (sandostatin) or somatostatin (Stilamin) | ||
|| | |||
|- | |- | ||
Line 355: | Line 406: | ||
|| amiodarones | || amiodarones | ||
|| | || | ||
|| | |||
|- | |- | ||
Line 361: | Line 413: | ||
|| anti-TB drugs | || anti-TB drugs | ||
|| Isoniazid (INH), Rifabutin (mycobutin), Ethambutal (Ethambutol; Etibi), Pyrazinamide (rifater), Streptomycin | || Isoniazid (INH), Rifabutin (mycobutin), Ethambutal (Ethambutol; Etibi), Pyrazinamide (rifater), Streptomycin | ||
|| | |||
|- | |- | ||
|| 59 | || 59 | ||
|| no | || no | ||
|| rifampin | || rifampin | ||
|| | || Rifadin, Rofact | ||
|| eliminated Sept ?.12 | |||
|- | |- | ||
Line 373: | Line 427: | ||
|| statins | || statins | ||
|| atorvastatin (Lipitor), fluvastatin (Lescol), simvastatin (Zocor), lovastatin (Mevacor), pravastatin (Pravachol), rosuvastatin (Crestor) | || atorvastatin (Lipitor), fluvastatin (Lescol), simvastatin (Zocor), lovastatin (Mevacor), pravastatin (Pravachol), rosuvastatin (Crestor) | ||
|| | |||
|} | |} | ||
== | == Related articles == | ||
{{Related Articles}} | |||
== | == Related articles == | ||
{{Related Articles}} | |||
[[Category: Legacy Pharmacy]] | |||
}} | |||
[[Category: Pharmacy]] | |||
Latest revision as of 12:49, 2021 November 25
Legacy Content
This page contains Legacy Content.- Explanation: Various changes happened after that see Pharmacy collection#Legacy Info for summary of changes over time
- Successor: Pharmacy collection
Click Expand to show legacy content.
- Start date of this list Jan 1.12
- End date of this list Sept ??.12
- Since folks were told to start using new list sometime in the beginning of sept with YES and NO ,when is actually the end date for this list? Good for Julie to know.Trish Ostryzniuk (talk) 19:36, 2012 September 20 (CDT)
List Outdated
- The new drug list (sept 25.12) reduces the workload of pharmacy collection. Final approval from steering committee for new list will be obtained Sept 10.12. There are number of drug groups that will be Yes and No only, and other eliminated. I have send everyone a copy of the list today so you can look at what is coming.Trish Ostryzniuk 10:56, 2012 September 7 (CDT)
{